Long Term Bio
Long only, biotech, healthcare, short only

Cellceutix: An Undiscovered Company Set To Rise In 2014

Cellceutix has been overlooked on the market because of its unknown status as a biotechnology company. It trades on the OTC which lacks a lot of coverage, which is part of the reason it is not well known. We believe that upcoming trials along with catalysts/presentations could lead the share price to rise in 2014 as people analyze the true value of the company. We believe that Cellceutix is a good long term stock to own in 2014 and beyond!

There are so many biotech companies out there that are looking to create new advances in cancer therapy. There are currently a lot of chemotherapy drugs that leave patients with a lot of toxic side effects. The hope now is

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details